- Genetic mutations are changes in the DNA sequence that can alter genetic information and, in some circumstances, contribute to disease. DNA contains the instructions required for the development, maintenance, and functioning of living organisms. When the DNA sequence changes, the effect can range from no detectable biological consequence to significant disruption of cellular processes. Genetic mutations are therefore fundamental to understanding genetic disorders, human variation, evolution, cancer biology, and molecular genetics.
- The term mutation is commonly used to describe a change in DNA, although modern genetics often uses the broader term genetic variant when referring to differences in DNA sequence. Not every genetic change is harmful. Many variants are harmless, some contribute to normal human diversity, and others can provide biological advantages or disadvantages depending on the circumstances. A mutation becomes particularly important in medical genetics when there is sufficient evidence that it contributes to a disease or abnormal biological phenotype.
- DNA is composed of four main nucleotide bases: adenine, thymine, cytosine, and guanine. The order of these bases forms the genetic sequence. A change involving even a single nucleotide can sometimes affect the function of a gene. However, the consequences depend on where the change occurs, whether it affects a functional genomic region, and how it influences the resulting RNA, protein, or regulatory process.
- Genetic mutations can occur in different parts of the genome. Some occur within protein-coding regions, where they can change the amino acid sequence of a protein. Others occur in introns, promoters, enhancers, untranslated regions, or other regulatory elements. A mutation outside a protein-coding region can still have an important biological effect if it changes gene expression, RNA processing, or other regulatory mechanisms.
- One of the simplest types of mutation is a substitution, in which one nucleotide is replaced by another. Substitutions are sometimes called single-nucleotide variants when they involve a single position in the genome. Depending on the location and molecular consequences, a substitution can be classified as synonymous, missense, nonsense, or another type of sequence change.
- A silent or synonymous mutation changes a DNA sequence without changing the amino acid encoded by the affected codon. Because the genetic code is redundant, different codons can specify the same amino acid. Although synonymous variants were traditionally considered biologically neutral, some can influence RNA processing, messenger RNA stability, translation efficiency, or other molecular processes. Their effects therefore need to be considered in their specific biological context.
- A missense mutation changes a codon so that a different amino acid is incorporated into the resulting protein. The effect can range from minimal to severe. If the substituted amino acid has similar chemical properties to the original, the protein may retain much of its normal function. If the substitution occurs at an important functional or structural site, however, it can substantially alter protein activity, stability, or interactions.
- A nonsense mutation converts a codon that normally specifies an amino acid into a premature termination signal. This can cause the production of a shortened protein that may be unstable or nonfunctional. In some cases, cells recognize the abnormal messenger RNA and eliminate it through a process known as nonsense-mediated decay, reducing production of the affected protein.
- Insertions and deletions, commonly referred to as indels, involve the addition or removal of one or more nucleotides. Their consequences depend partly on the number of nucleotides inserted or deleted and their position within the gene. When an insertion or deletion changes the grouping of nucleotides into codons, it can produce a frameshift mutation that alters the downstream amino acid sequence.
- Frameshift mutations can have substantial effects because the reading frame of a protein-coding sequence is changed from the point of the mutation onward. The altered sequence may eventually encounter a premature stop codon, resulting in a shortened protein. Consequently, frameshift variants in important genes can contribute to severe genetic disorders.
- Some mutations affect the boundaries or signals required for proper RNA splicing. During gene expression, non-coding introns are removed and coding or functional exons are joined to form mature RNA. Splice-site mutations can cause abnormal exon inclusion, exon skipping, intron retention, or other changes in RNA processing. Abnormal splicing can consequently produce an altered or nonfunctional protein.
- Genetic mutations are not limited to individual genes. Larger DNA changes can affect substantial genomic regions. Structural variants include deletions, duplications, inversions, insertions, and translocations. These changes can alter gene dosage, disrupt genes, change regulatory regions, or rearrange genomic material. Some structural variants are harmless, whereas others can contribute to developmental disorders, genetic syndromes, or cancer.
- Copy number variations are genomic differences involving changes in the number of copies of particular DNA segments. A deletion can reduce the number of copies, while a duplication can increase them. Changes in gene dosage can disturb cellular processes when the amount of a gene product needs to remain within a specific range. Copy number changes are therefore an important source of genetic variation and disease-associated genomic alterations.
- Another specialized type of mutation involves repeat expansions. Certain DNA sequences contain repeated nucleotide patterns that can increase in number during DNA replication or transmission between generations. When a repeat expands beyond a particular threshold, it can interfere with gene expression, RNA function, or protein production. Repeat expansion mechanisms are associated with several inherited neurological and other disorders.
- Genetic mutations can also occur in regulatory regions of the genome. Promoters, enhancers, silencers, and other regulatory elements control when and where genes are expressed. A mutation affecting one of these regions may cause a gene to be expressed at an inappropriate level or in an inappropriate tissue. In developmental biology, even relatively subtle changes in gene regulation can have significant consequences.
- Mutations can affect genes involved in many different cellular processes. A variant affecting an enzyme may interfere with metabolism, while a change in a receptor gene may alter cellular signaling. Mutations in structural proteins can affect tissues such as muscle, bone, or connective tissue. Changes in transcription factors can alter the expression of many downstream genes. Mutations in DNA repair genes can increase genomic instability and allow additional mutations to accumulate.
- The effect of a mutation can also depend on whether it produces a loss of function or a gain of function. Loss-of-function variants reduce or eliminate the normal activity of a gene product. Gain-of-function variants can produce increased, abnormal, or newly acquired activity. Other mechanisms include dominant-negative effects, in which an altered protein interferes with the function of a normal protein, and changes in gene dosage.
- Some mutations affect only one copy of a gene, while others affect both copies. In autosomal dominant disorders, a pathogenic variant in one copy may be sufficient to produce disease. In autosomal recessive disorders, disease generally requires pathogenic variants affecting both copies of the relevant gene. The molecular effect of a mutation and the inheritance pattern are therefore closely connected.
- Mutations can occur in germline cells or in somatic cells. Germline mutations are present in reproductive cells or their precursors and can potentially be passed to offspring. Somatic mutations occur in body cells and are generally restricted to the individual. Somatic mutations have a particularly important role in cancer because cancer cells can acquire mutations affecting cell division, DNA repair, apoptosis, and other pathways.
- Some mutations are inherited from parents, while others arise spontaneously. De novo mutations occur for the first time in an individual and are not detected in the corresponding parental genetic material. They can arise during the formation of reproductive cells or during early embryonic development. De novo mutations can contribute to genetic disorders even when there is no previous family history of the condition.
- Mutations can arise through several biological mechanisms. Errors during DNA replication are one source of new mutations. Although DNA polymerases and associated repair systems provide substantial accuracy, occasional replication errors can remain after proofreading and repair. Over many rounds of cell division, such changes can accumulate within cells.
- DNA can also be damaged by endogenous processes. Normal cellular metabolism can generate reactive molecules capable of modifying DNA bases or damaging DNA strands. Cells have multiple DNA repair pathways that detect and correct different forms of damage. When these mechanisms fail, damaged DNA can sometimes become permanently incorporated into the genome as a mutation.
- Environmental factors can also contribute to DNA damage and mutation. Ultraviolet radiation, ionizing radiation, and certain chemical agents can damage DNA. Some infectious agents can indirectly contribute to genomic instability or influence cellular processes associated with cancer. However, the relationship between a particular exposure and a specific mutation depends on many factors, including dose, duration, tissue type, cellular repair mechanisms, and genetic susceptibility.
- Mutations are also an important source of genetic variation in populations. New DNA changes can be transmitted across generations when they occur in the germline. Most variants have little or no harmful effect, but genetic variation provides the raw material on which evolutionary processes act. Natural selection, genetic drift, migration, and other population processes can influence the frequency of variants over time.
- The biological effect of a mutation is influenced by its genomic context. A change in an essential protein-coding region may have a very different consequence from an identical nucleotide change occurring in a nonfunctional region. Even within the same gene, different mutations can produce different levels of residual protein activity and therefore different clinical manifestations.
- This variation contributes to genotype-phenotype relationships. The genotype describes the genetic variant or combination of variants an individual carries, while the phenotype refers to the resulting observable or biological characteristics. The relationship between genotype and phenotype can be modified by additional genes, epigenetic factors, environmental influences, age, and other biological variables.
- Some mutations show variable expressivity, meaning that individuals carrying the same disease-associated variant can exhibit different manifestations or degrees of severity. Incomplete penetrance can also occur, in which some individuals carrying a pathogenic variant do not develop the associated phenotype. These concepts demonstrate why identifying a mutation does not always provide a complete prediction of disease expression.
- Modern genetic testing allows researchers and clinicians to identify mutations using increasingly sophisticated technologies. Sanger sequencing can examine selected DNA regions, while next-generation sequencing can analyze many genes simultaneously. Targeted gene panels, whole-exome sequencing, and whole-genome sequencing can be used when the underlying genetic cause is uncertain or when a broader analysis is appropriate.
- Identifying a genetic variant does not automatically establish that it causes disease. Variants are interpreted using information from population databases, family studies, functional experiments, clinical observations, computational analyses, and other evidence. Some variants remain classified as variants of uncertain significance, meaning that available evidence is insufficient to determine their clinical significance confidently.
- Understanding genetic mutations is important not only for diagnosis but also for developing treatments. If a disease results from loss of a functional protein, researchers may investigate gene replacement, enzyme replacement, or other approaches. If abnormal RNA processing is involved, RNA-based therapies may be considered. When a specific DNA change can be precisely targeted, genome editing technologies are being investigated as potential therapeutic approaches.
- Genetic mutations are also central to cancer genetics. Unlike inherited germline variants, many mutations found in tumors are acquired during a person’s lifetime. These somatic changes can affect oncogenes, tumor suppressor genes, DNA repair genes, and other pathways controlling cell growth and survival. Understanding tumor mutations can help researchers classify cancers and identify molecular targets for therapy.
- Overall, genetic mutations encompass a broad range of DNA changes, from single-nucleotide substitutions to large genomic rearrangements. Their effects depend on the affected sequence, genomic location, molecular mechanism, inheritance pattern, and interaction with other biological factors. Some mutations are harmless, some contribute to normal genetic diversity, and others cause or increase susceptibility to disease.
